Skip to content

Subcutaneous irrigation with 2% aqueous chlorhexidine vs. 0.9% saline solution in open bariatric surgery: randomized controlled trial.

Intraoperative subcutaneous irrigation with 2% aqueous chlorhexidine vs. 0.9% saline solution and surgical wound infection rate in open bariatric bypass surgery: a prospective randomized controlled trial.

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
REBEC
Registry ID
RBR-5mcym7y
Enrollment
200
Registered
2026-02-27
Start date
2025-03-01
Completion date
Unknown
Last updated
2026-03-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Surgical Wound Infection

Interventions

This is a randomized, controlled, two-arm, single-blind clinical study. A total of 148 patients were included. 71 patients were randomized to the 2% aqueous chlorhexidine intervention group and 77 pat

Sponsors

Irmandade da Santa Casa de Misericordia de Curitiba
Lead Sponsor
Irmandade da Santa Casa de Misericordia de Curitiba
Collaborator

Eligibility

Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: Paciente who have undergone open bariatric bypass surgery; patients >= 18 years old and <=65 years old; both sexes (female and male)

Exclusion criteria

Exclusion criteria: Patients allergic to chlorhexidine; videolaparoscopic bariatric surgery; sleeve gastrectomy

Design outcomes

Primary

MeasureTime frame
Our primary outcome was the surgical wound infection rate, and we expected to find a decrease with the use of 2% aqueous chlorhexidine. However, similar rates of surgical wound infection were observed in both groups. 22 patients presented with superficial surgical wound infection in the chlorhexidine group (30.9%) and 19 patients presented with surgical wound infection in the saline group (24.7%), with only one infection classified as deep, requiring surgical intervention in this group. Based on Pearson's chi-square test, no statistically significant difference was observed between the groups, with a p-value of 0.501.

Secondary

MeasureTime frame
No secondary outcomes are expected

Countries

Brazil

Contacts

Public ContactOdair Neto

Hospital Santa Casa de Curitiba

drodair.neto@gmail.com+55(44)998145880

Outcome results

None listed

Source: REBEC (via WHO ICTRP) · Data processed: Mar 14, 2026